Finch Therapeutics Group, Inc. Profile Avatar - Palmy Investing

Finch Therapeutics Group, Inc.

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that i…

Biotechnology
US, Somerville [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Finch Therapeutics Group, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Finch Therapeutics Group, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Finch Therapeutics Group, Inc..

End of FNCH's Analysis
CIK: 1733257 CUSIP: 31773D101 ISIN: US31773D2009 LEI: - UEI: -
Secondary Listings
FNCH has no secondary listings inside our databases.